semaglutide and cardiovascular outcomes in diabetes study news risk reduction with once-weekly subjects with type 2 Insights into semaglutide cardiovascular research:

Clinical research shows tirzepatide users achieve an average of 20 percent body weight reduction, compared to 15 percent with semaglutide

A narrative review of 10 interventional studies also demonstrated that mindfulness or meditation may lead to less cognitive decline, a decrease in perceived stress, and positive changes in brain functional connectivity, volume, and blood flow in people with AD, dementia, or dementia-related memory conditions [228]

This means retatrutide attacks obesity from both sides: reducing caloric intake (GLP-1R/GIPR) while simultaneously increasing caloric expenditure (GCGR)

Military & first responders get 20% every order